CKPT - Checkpoint Therapeutics Inc
IEX Last Trade
2.35
0.010 0.426%
Share volume: 155,233
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.34
0.01
0.43%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-12 | 2022-11-10 | 2023-03-31 | 2023-05-15 | 2023-08-14 | 2023-11-13 | 2024-03-22 | |
| Total revenue | 52.000 K | 18.000 K | 48.000 K | 74.000 K | 35.000 K | 31.000 K | 31.000 K | 6.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 52.000 K | 18.000 K | 48.000 K | 74.000 K | 35.000 K | 31.000 K | 31.000 K | 6.000 K | |
| -65.38% | 166.67% | 54.17% | -52.70% | -11.43% | 0.00% | -80.65% | |||
| Operating expenses | 16.913 M | 14.182 M | 10.712 M | 16.718 M | 18.118 M | 16.226 M | 7.732 M | 10.175 M | |
| Selling general and admin | 2.243 M | 2.129 M | 1.846 M | 2.482 M | 2.292 M | 2.281 M | 2.236 M | 1.876 M | |
| Research and development | 14.670 M | 12.053 M | 8.866 M | 14.236 M | 15.826 M | 13.945 M | 5.496 M | 8.299 M | |
| Total expenses | 16.913 M | 14.182 M | 10.712 M | 16.718 M | 18.118 M | 16.226 M | 7.732 M | 10.175 M | |
| -16.15% | -24.47% | 56.07% | 8.37% | -10.44% | -52.35% | 31.60% | |||
| Operating income | -16.861 M | -14.164 M | -10.664 M | -16.644 M | -18.083 M | -16.195 M | -7.701 M | -10.169 M | |
| Ebit | -16.861 M | -14.164 M | -10.664 M | -16.644 M | -18.083 M | -16.195 M | -7.701 M | -10.169 M | |
| Pretax income | -16.848 M | -14.142 M | -10.612 M | -21.022 M | -10.474 M | -16.521 M | -5.724 M | -19.128 M | |
| -16.06% | -24.96% | 98.10% | -50.18% | 57.73% | -65.35% | 234.17% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -16.848 M | -14.142 M | -10.612 M | -21.022 M | -10.474 M | -16.521 M | -5.724 M | -19.128 M | |
| 16.06% | 24.96% | -98.10% | 50.18% | -57.73% | 65.35% | -234.17% | |||
| Net income | -16.848 M | -14.142 M | -10.612 M | -21.022 M | -10.474 M | -16.521 M | -5.724 M | -19.128 M | |
| 16.06% | 24.96% | -98.10% | 50.18% | -57.73% | 65.35% | -234.17% |